Heart Failure Doubles Risk of Dying From COVID-19
One expert cautions that data from the pandemic’s first-wave may not reflect the current state of treatment.
One expert cautions that data from the pandemic’s first-wave may not reflect the current state of treatment.
Jagmeet Singh joins Harriette Van Spall to discuss artificial intelligence in the realm of heart failure.
Interventionalists say it’s now time to make a dent in the complication rate, whether by strict protocols or smaller devices.
Even at a mean age of 85 years, there is still time to accrue mortality benefits from potent LDL-lowering therapies.
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
The three calculators focus on isolated tricuspid repair and replacement, SAVR after TAVI, and multivalve procedures.
Lower risks of death and MACE in statin users are intriguing, but need to be confirmed in randomized trials, experts say.
Monika Safford, MD, explains how peer coaching and practice facilitation may improve systolic blood pressure for patients in the US “Black Belt.”
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.
Fighting for sinus rhythm might be crucial for the essential social needs of patients with the arrhythmia, one expert says.
All but one of our top stories this month stemmed from ACC 2024, but not all were from the main tent sessions.